These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11593338)

  • 41. Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.
    Hermiston TW; Kuhn I
    Cancer Gene Ther; 2002 Dec; 9(12):1022-35. PubMed ID: 12522441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Third international Dresden symposium on immunotherapy of cancer.
    Schmitz M; Bornhauser M; Ockert D; Rieber EP
    Cancer Res; 2001 Apr; 61(8):3524-8. PubMed ID: 11309317
    [No Abstract]   [Full Text] [Related]  

  • 43. Biology and therapy of malignant solid tumors in childhood.
    van den Berg H
    Cancer Chemother Biol Response Modif; 2002; 20():605-25. PubMed ID: 12703226
    [No Abstract]   [Full Text] [Related]  

  • 44. International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts.
    Anticancer Res; 1997; 17(6A):3985-4101. PubMed ID: 9429549
    [No Abstract]   [Full Text] [Related]  

  • 45. [New acquisitions in tumor biology related to the antineoplastic therapy. With reference to the XIth International Cancer Congress].
    Badellino F; Reali R
    Minerva Med; 1976 Mar; 67(14):885-97. PubMed ID: 4748
    [No Abstract]   [Full Text] [Related]  

  • 46. Molecular therapy for cancer.
    Deisseroth A; Guo D; Wang T; Fujii T; Fu SQ; Cote R; Savinov S; Liu F; Loewe R; Pizzorno G; Austin D; Crystal R; Chung I
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S5-7. PubMed ID: 9619264
    [No Abstract]   [Full Text] [Related]  

  • 47. American Society of Clinical Oncology--40th Annual Meeting. Selected highlights. 5-8 June 2004, New Orleans, LA, USA.
    Erlich R; Harrison R
    IDrugs; 2004 Jul; 7(7):621-4. PubMed ID: 15243857
    [No Abstract]   [Full Text] [Related]  

  • 48. Targeted prodrug approaches for hormone refractory prostate cancer.
    Aloysius H; Hu L
    Med Res Rev; 2015 May; 35(3):554-85. PubMed ID: 25529338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular therapies for colorectal cancer metastatic to the liver.
    Mayer-Kuckuk P; Banerjee D; Kemeny N; Fong Y; Bertino JR
    Mol Ther; 2002 May; 5(5 Pt 1):492-500. PubMed ID: 11991739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Report on the ISBTC mini-symposium on biologic effects of targeted therapeutics.
    Atkins MB; Carbone D; Coukos G; Dhodapkar M; Ernstoff MS; Finke J; Gajewski TF; Gollob J; Lotze MT; Storkus W; Weiner LM
    J Immunother; 2007 Sep; 30(6):577-90. PubMed ID: 17667521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical studies on the combined immunochemotherapy with a streptococcal preparation (Picibanil) and other anticancer drugs.
    Misawa S; Sawai K; Takino T; Masuda M; Abe T; Kawai K
    Nihon Gan Chiryo Gakkai Shi; 1979 Jun; 14(3):291-305. PubMed ID: 479655
    [No Abstract]   [Full Text] [Related]  

  • 52. Targeting cancer therapy.
    Begent RH
    Br J Cancer; 1999 Jul; 80 Suppl 1():104-9. PubMed ID: 10466768
    [No Abstract]   [Full Text] [Related]  

  • 53. Exploiting tumour biology: novel approaches in cancer therapy. ESBP Otzenhausen Conference, 6-8th September 1993.
    Gescher A; Mantovani A
    Ann Oncol; 1994 Mar; 5(3):205-7. PubMed ID: 7910481
    [No Abstract]   [Full Text] [Related]  

  • 54. [Biotherapy of solid tumors].
    Moiseenko VM
    Vopr Onkol; 1998; 44(1):120-5. PubMed ID: 9578746
    [No Abstract]   [Full Text] [Related]  

  • 55. Approaches to gene-directed enzyme prodrug therapy (GDEPT).
    Springer CJ; Niculescu-Duvaz I
    Adv Exp Med Biol; 2000; 465():403-9. PubMed ID: 10810644
    [No Abstract]   [Full Text] [Related]  

  • 56. Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.
    Wallace PM; Senter PD
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):505-12. PubMed ID: 7885077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
    Fisher M; Yang LX
    Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunotherapy of Cancer. Preface.
    Wang XY; Fisher PB
    Adv Cancer Res; 2015; 128():xiii-xv. PubMed ID: 26216638
    [No Abstract]   [Full Text] [Related]  

  • 59. AIMECS 07 - Sixth AFMC International Medicinal Chemistry Symposium: recent approaches in anticancer therapy.
    Valla V
    IDrugs; 2007 Sep; 10(9):614-7. PubMed ID: 17786841
    [No Abstract]   [Full Text] [Related]  

  • 60. First symposium of novel molecular targets for cancer therapy.
    Politi PM; Senderowicz AM
    Oncologist; 2001; 6(2):207-12. PubMed ID: 11306733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.